#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16436	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2130	767.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	963	C,G,T	852,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16436	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2130	767.1	0	HET	.	.	.	C451T	.	451	451	C	681	681	C	960	C,T	673,208	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30388	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3529	858.7	0	.	n	.	0	T695C	SNP	695	695	T	1000	1000	C	924	C,T	846,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30388	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3529	858.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2276	2276	C	943	C,T	854,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30388	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3529	858.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2350	2350	A	938	A	850	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30388	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3529	858.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2902	2902	C	1016	C	936	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2364	folP	855	855	100.0	folP.l6.c4.ctg.1	1445	162.7	1	SNP	p	R229S	1	.	.	685	687	AGC	987	989	AGC	242;244;244	A;G;C	224;224;223	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6430	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3311	193.5	1	SNP	p	S91F	1	.	.	271	273	TTC	567	569	TTC	212;213;218	T;T;C	189;191;195	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6430	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3311	193.5	1	SNP	p	D95G	1	.	.	283	285	GGC	579	581	GGC	217;214;215	G;G;C	193;190;192	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6430	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3311	193.5	1	SNP	p	G95N	0	.	.	283	285	GGC	579	581	GGC	217;214;215	G;G;C	193;190;192	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1358	124.4	0	.	p	.	0	A39T	NONSYN	115	117	GCC	464	466	ACC	207;206;204	A,G;C;C	185,1;187;184	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1358	124.4	0	.	p	.	0	R44H	NONSYN	130	132	CGC	479	481	CAC	196;199;196	C;A,C;C	176;179,1;176	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1358	124.4	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	662	664	CAC	219;218;221	C;A;C	201;196;203	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1358	124.4	1	SNP	p	G45D	0	.	.	133	135	GGC	482	484	GGC	199;200;198	G;G;C	180;181;181	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	972	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	946	102.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5954	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2876	206.6	1	SNP	p	D86N	0	.	.	256	258	GAC	546	548	GAC	230;227;225	G,A;A,AG;C	206,1;214,1;202	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5954	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2876	206.6	1	SNP	p	R87W	0	.	.	259	261	CGT	549	551	CGT	226;223;223	C;G;T	202;201;198	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5954	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2876	206.6	1	SNP	p	R87I	0	.	.	259	261	CGT	549	551	CGT	226;223;223	C;G;T	202;201;198	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5954	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2876	206.6	1	SNP	p	S87R	1	.	.	259	261	CGT	549	551	CGT	226;223;223	C;G;T	202;201;198	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5954	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2876	206.6	1	SNP	p	S88P	0	.	.	262	264	TCC	552	554	TCC	222;226;227	T;C;C	201;202;206	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5022	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2594	193.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1482	1484	GGC	227;227;227	G;G;C	207;211;210	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4486	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2450	182.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1275	1277	GCC	245;249;252	G;C;C	216;218;223	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4486	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2450	182.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1278	1280	ATG	250;250;246	A;T;G	222;222;220	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4486	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2450	182.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1290	1292	ACC	249;248;247	A;C;C	223;225;225	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4486	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2450	182.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1290	1292	ACC	249;248;247	A;C;C	223;225;225	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4486	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2450	182.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1791	1793	ACC	215;217;219	A;C,T;C	187;191,1;197	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4486	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2450	182.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1845	1847	GCG	223;222;220	G;C;G	205;203;200	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4486	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2450	182.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1845	1847	GCG	223;222;220	G;C;G	205;203;200	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4486	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2450	182.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1968	1970	GGT	187;187;185	G;G,A;T	163;164,1;163	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4486	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2450	182.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1977	1979	AGC	175;177;176	A;G;C	156;154;154	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4486	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2450	182.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1995	1997	CCG	163;163;164	C,G;C,G;G,C	120,9;120,1;119,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6400	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3201	199.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1717	1719	CCG	244;245;241	C,G;C;G	215,1;219;211	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2570	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1668	152.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	449	449	C	175	C	155	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3194	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1531	207.5	0	.	p	.	0	G48E	NONSYN	142	144	GGA	383	385	GAA	267;269;269	G;A;A	240;238;242	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3194	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1531	207.5	0	.	p	.	0	G210R	NONSYN	628	630	GGA	869	871	AGA	283;282;282	A;G;A	260;253;251	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3194	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1531	207.5	0	.	p	.	0	S217G	NONSYN	649	651	AGT	890	892	GGT	276;278;276	G;G;T	250;257;252	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3194	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1531	207.5	1	SNP	p	G120K	1	.	.	358	360	AAG	599	601	AAG	262;259;259	A;A;G,C	236;237;231,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3194	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1531	207.5	1	SNP	p	A121N	1	.	.	361	363	AAC	602	604	AAC	263;263;262	A;A;C	237;242;237	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3194	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1531	207.5	1	SNP	p	N121D	0	.	.	361	363	AAC	602	604	AAC	263;263;262	A;A;C	237;242;237	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11666	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4675	248.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1250	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1062	117.3	1	SNP	p	V57M	1	.	.	169	171	ATG	511	513	ATG	257;258;257	A;T;G	226;233;234	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
